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Therapy for severe chronic lung disease currently includes the administration of supplemental 
oxygen to prevent breathlessness and tissue hypoxia. Although effective, this therapy is 
unnecessarily costly, because oxygen is administered to the patient during expiration as well as 
inspiration. To eliminate this inefficiency, a delivery system that senses the inspiratory effort and 
delivers oxygen to the patient only during inspiration was developed. The 11  5  8-cm flow 
control unit attaches easily to a portable oxygen supply. The components of the system have an 
expected life of five years, and the 9-Volt battery provides power for about one month of use. 
Manual controls permit accommodation to the respiratory pattern of the patient. Preliminary 
evaluation of the system showed that its effectiveness in producing tissue oxygenation is similar 
to that of continuous oxygen systems. The system has potential applications in ambulatory 
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Ambulatory oxygen therapy is becoming an increasingly accepted part of the regimen for the 
management of patients with chronic obstructive pulmonary disease (COPD). In 1976 Levine et 
al.[1] documented overall clinical improvement in patients with COPD who were receiving 
continuous low-flow oxygen therapy during daily activities. In their study, patient comfort was 
greatly improved by the development of a nasal cannula made of unobtrusive, soft plastic. After 
a month of continuous oxygen delivered by nasal cannula, five of the six patients were able to 
participate in a rehabilitation program, and the management of respiratory and cardiac problems 
was simpler. The authors stated that "long-term continuous O2 therapy caused significant clinical 
improvement in every patient." 
 
Two recent reports, one from Great Britain and the other from the United States, have confirmed 
the benefits of long-term oxygen therapy. In the American study [2] results in patients with 
COPD, randomly assigned to continuous oxygen therapy (19 hours/day) were compared with 
those in patients receiving oxygen therapy only nocturnally (12 hours/day). The results showed 
the mortality of the nocturnal oxygen group to be almost twice (1.95 times) that of the 
continuous oxygen group. The British study [3] compared 15-hour nocturnal oxygen treatment 
with a treatment regimen that did not involve supplemental oxygen, administered to a control 
group. During a five-year period the mortality in the oxygen group (12 per cent/year) was less 
than half that of the control group (29 per cent/ year). Based on this and other research, oxygen 
administration has become an accepted part of the therapy for chronic lung disease. The results 
to be expected are 1) increased exercise tolerance, 2) reversal of hypoxia-induced pulmonary 
hypertension, 3) reduction in hypoxia-induced polycythemia, and 4) improved mental status [4]. 
 
Long-term continuous oxygen therapy for ambulatory patients became practical in 1967, with the 
introduction of a portable system that used liquid oxygen [5]. The light-weight apparatus 
contained a four-hour supply of oxygen when set at a flow rate of 2 L/minute. A reservoir tank of 
liquid oxygen installed in the patient's home allowed refilling of the portable system. The 
effectiveness of a liquid oxygen source was proved by Petty and Finigan [6], who showed that 
liquid oxygen systems are as effective as compressed oxygen sources. Alternatively, an oxygen 
concentrator may be used in the home [7]. This machine uses a molecular sieve to separate room 
air into oxygen and nitrogen, collecting the oxygen and delivering it to the patient. Continuous 
oxygen treatment from the oxygen concentrator is five to seven times less costly than the same 
treatment from an oxygen cylinder. The currently used oxygen administration systems for 
chronic therapy, incorporating either liquid oxygen or an oxygen concentrator, still have 
drawbacks. The liquid oxygen apparatus is expensive, as is the refilling of the home reservoir. In 
addition, the 3.8-kg portable system is too heavy for patients with advanced stages of COPD. 
The oxygen concentrator requires a large initial investment and tethers the ambulatory patient.  
 
An inherent inefficiency of most systems currently used is that a continuous flow of oxygen is 
delivered to the patient, although that delivered during expiration is obviously wasted. An 
automatic system that delivers oxygen only during inspiration could, in principle, improve the 
efficiency of current oxygen systems by reducing both operating costs and the size and weight of 




INSPIRATION-TRIGGERED DELIVERY SYSTEM 
 
Figure l is a block diagram of the demand delivery system. The system incorporates a high-
sensitivity pressure sensor in line with a conventional nasal cannula to monitor the pressure 
fluctuations in the nares inherent to respiration. Sharp negative going pressure waves at the onset 
of inspiration serve as a trigger signal, initiating gas flow for a preselected time-out period. In 
particular, when the absolute value of this negative pressure signal exceeds a threshold value, the 





Figure 1.  Component configuration for the demonstrator prototype. 
 
 
Figure 2 illustrates the pressure signal recorded with such a transducer through a nasal cannula 
during normal quiet breathing in a healthy volunteer. In this record, made with a sensitive 
Statham #P23BB venous blood pressure transducer, a downward deflection represents negative 
pressure, or inspiration, and an upward deflection represents positive pressure, or expiration. The 
calibration shows that the signal amplitude is in the range of 0.5 to l.0 mmHg, similar to that 
reported earlier by Guyatt and associates [8]. The inspiratory phase, which begins with a sharp 
negative deflection, constitutes less than half of the respiratory cycle. The pathologic features of 
COPD, i.e., the loss of elastic recoil and airway collapse, would cause exaggeration of the length 
of expiration but would not be expected to change the shape of the inspiratory portion of the 
cycle greatly. Accordingly, we selected the negative deflection in pressure at the beginning of 










Figure 2. Initial measurement of nasal breathing with a nasal cannula used as a 




Our first prototype was equipped with two control knobs, allowing the patient to adjust manually 
both the trigger threshold level and the duration of the delivered oxygen pulse. The adjustable 
duration feature permitted two qualitatively different modes of operation of the system (fig. 3).  
 
In what we have called the manual mode, the user selects a gas pulse duration, in the range of l to 
2 seconds, that is roughly the same as the duration of inspiratory effort. With each inspiration the 
user receives a single pulse of gas. If the duration of inspiration changes, as in exercise, the user 
can manually adjust the duration of the gas pulse.  
 
In what we have called the automatic mode, the user sets the duration in the range of 0.1 to 0.2 
seconds, which is significantly less than the duration of normal inspiration. This system delivers 
a brief pulse of gas, terminates flow, and then continues sensing. If inspiration continues, 
negative pressure is quickly registered and another pulse of gas is delivered. The overall effect is 
to produce a train of gas pulses that is nearly coincident in overall duration with the inspiratory 
effort. Thus, the automatic mode adjusts to changes in the duration of inspiratory effort, and flow 







Figure 3. The concept of the demand delivery system involves delivery of a pulse of 






Figures 4 and 5 illustrate the performance of the demand delivery system in both the manual and 
automatic modes of operation. In these graphic records, the top channel illustrates pressure 
within the nasal cannula in the form of the transducer output signal. The second channel 
illustrates the state of the control valve, either open or closed, and the third channel illustrates gas 
flow through the nasal cannula as measured with a pneumotachograph. In the manual mode (fig. 
4) the record illustrates that a slight negative pressure sensed by the transducer (an upward 
deflection represents negative pressure) causes the valve to open and gas to be delivered for the 
preset pulse duration of l second. In this three-breath record, the length of inspiratory effort is 






Figure 4.  Performance record of the demonstrator prototype in the manual mode of 
operation. The exponential decay in oxygen flow is caused by discharge of the 
pneumatic capacitance between the demand value and the flow control valve. Tilt of 













Figure 6.  Various forms of noise that could occur during respiration and a record of 








Figure 7. Performance record of the demonstrator prototype in the automatic mode of 
operation. Noise was introduced by shaking the oxygen tubing, and a single ill-timed 
pulse of gas (arrow) was delivered when the system interpreted the noise as an 




In the automatic mode (fig. 5) the pulse of shorter duration allows the transducer to sense for 
inspiration more frequently. While the transducer is sensing, no gas is flowing to the patient. 
This interruption in flow, or off-time, is inherent in the automatic mode and can be compensated 
for by increasing the flow setting slightly to achieve a desired mean flow rate. It is easy to see 




Response to Noise 
 
In a further performance test we investigated the function of the system when challenged by 
various forms of noise. We observed that speaking, talking, and shouting all generated positive 
pressure at the transducer and did not activate the flow control valve (fig. 6). Noise due to 
shaking and crimping the short tube that connects the outlet barb of the oxygen supply to the 
inlet port of the unit can introduce occasional spurious pulses of flow (fig. 7, arrows). Should the 
unit fail; the user can quickly bypass the control valve by directly connecting nasal cannula 
tubing to the oxygen supply, as it is normally done for continuous oxygen delivery.  
 
The portable prototype (fig. 8) included a sensitive pressure transducer (Microswitch, Series 160) 
and a bistable electronic latching valve (Reedex). Both were powered by a common 9-Volt 
transistor radio battery that was also contained within the Unibox. The estimated life of the 
battery is one month of heavy use. The sensitivity knob on the top of the unit controlled the 
trigger threshold, corresponding to the strength of inspiration required to cause the electronic 
system to open the valve. The duration knob controlled the duration of the pulse of oxygen flow. 
As an aid to adjustment of sensitivity, we incorporated a light-emitting diode (LED) into the 
circuitry that would flash coincident with the valve opening. The LED was placed next to the 
control knobs, allowing the user to monitor its display, while adjusting the sensitivity control 
knob. When the light flashed with every breath, the sensitivity was properly adjusted. 
 
Another added feature was a test position on the power switch. This switch position allowed the 
user to activate the demand valve manually to ensure that it was working properly. We had 
noticed in developing the system that it was difficult to detect the flow of gas through properly 
positioned nasal prongs, when flow occurred strictly during inspiration. In his sense, treatment 
by demand delivery of oxygen is much more comfortable than treatment with continuous 
oxygen--so much so that it is difficult to notice the gas flow. Using the test switch with the unit 
turned on and connected to the oxygen supply, the user could test the system by placing the nasal 
cannula close to the cheek and noticing a puff of gas. Such a test would reassure the user that the 





As an initial test of the effectiveness of our unit, we performed the following evaluation on a 
normal healthy subject. Transcutaneous PO2 was measured on the subject's forearm, as an 
indicator of systemic tissue oxygen tension, with a Novametrics Model 809 TcPO2 sensor. The 
9 
 
subject was careful to maintain a constant breathing pattern, as changes in depth and rate of 
respiration will affect the TcPO2 measurements. Figure 9 illustrates the results of the study, 
showing that an intermittent flow system can produce therapeutic increases in tissue oxygen 




Figure 8. Left, inspiration-triggered delivery system in its packaged form. Right, 




Figure 9. Transcutaneous oxygen pressure as measured on the forearm of a single 
subject, breathing room air, continuous oxygen, or intermittent oxygen. Each bar 
represents the mean of eight to ten separate trials, including room air breathing and 






The system described is by no means the first to permit oxygen delivery in phase with 
inspiration. In 1962 the Palm Breathing Device [9] was developed for intermittent oxygen 
therapy. During inspiration, the patient induced a flow of oxygen by depressing the control 
button with the thumb; flow was arrested when the button was released. The system was 
inexpensive and simple, but the manual control made it highly impractical for other than short-
term use by well-motivated patients. In 1972 the first portable automatic delivery system was 
developed for ambulatory patients [10]. In this system, referred to as the Automatic Belt 
Breathing Device, the flow of oxygen was activated by a switch contained in a special belt worn 
by the patient. Triggered by expansion of the chest or abdomen, the system proved effective but 
was not widely accepted because the belt was uncomfortable and subject to false flow triggers 
with changes in body position. The designers of these systems realized the potential savings of a 
demand oxygen system; however, they lacked the technology to implement such a system 
successfully. Our goal was to design and build an inspiration-triggered oxygen delivery system 
that would be practical, unobtrusive, and efficient and that would not require extensive patient 
cooperation. 
 
The inspiration-triggered delivery system described in this paper includes an electrically 
controlled valve that delivers therapeutic oxygen to the patient coincident with inspiration. 
Modern electronic technology allowed packaging of the entire system in a small, light-weight 
plastic box (approximate dimensions, 11  8  5 cm; weight, 130 g). The components are 
durable and should last approximately five years (excluding the battery). A 9-Volt transistor 
radio battery powers the system and provides energy for about one month of heavy use. To 
ensure patient comfort and compatibility, the system can be adjusted to match the patient's 
respiratory effort and length of inspiration. Preliminary laboratory testing showed that the system 
is as effective as continuously delivered oxygen in elevating tissue oxygen concentration.  
 
Because it delivers oxygen only during inspiration, the device could reduce the cost of oxygen 
therapy, reduce the size of the necessary apparatus, or both. Although designed to facilitate 
portable liquid oxygen delivery; the system has applications in other areas. For example, the unit 
could be used with conventional oxygen outlets in hospitals to reduce the cost of inpatient 
oxygen therapy. Its effective operation and wide range of applications would seem to ensure a 
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